Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cediranib in Malignant Mesothelioma
NCT00309946Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 2005
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cediranib in malignant mesothelioma, sponsored by National Cancer Institute. Started Dec 2005; status: completed.
02
Drugs
cediranib
03
Conditions
malignant mesothelioma
Beyond the preview
Go deeper on NCT00309946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00309946.